comparemela.com
  1. Home
  2. Live Updates
  3. Inds Kira - Breaking News

Latest Breaking News On - Inds kira - Page 1 : comparemela.com

Kira gets clearance for bifunctional biologic trial in China, Australia

Kira Pharmaceuticals has received clearances in China and Australia to commence Phase II trials of KP104 for IgAN and C3G.

ChinaAustraliaChineseAustralianFrederick beddingfieldInds kiraAustralian therapeutic goods administrationChinese national medical products administrationDrug administrationRobina weermeijerOrphan drug designation

Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia

/PRNewswire/ Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases,.

AustraliaChinaCambridgeCambridgeshireUnited kingdomChineseAustralianFrederick beddingfieldInds kiraAustralian therapeutic goods administrationPrnewswire kira pharmaceuticalsChinese national medical products administrationDrug administrationOrphan drug designationKira pharmaceuticals

Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Au

CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ — Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases,.

AustraliaChinaCambridgeCambridgeshireUnited kingdomChineseAustralianFrederick beddingfieldInds kiraAustralian therapeutic goods administrationChinese national medical products administrationDrug administrationOrphan drug designation

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.